Recruiting Narcolepsy Studies in Orlando
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), and Idiopathic Hypersomnia (IH) are rare conditions that make people feel very sleepy during the day (often referred to as excessive daytime sleepines...
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Narcolepsy without cataplexy or Narcolepsy Type 2 (NT2) is a lifelong condition that makes people very sleepy during the day, regardless of how much sleep they get at night. People with NT2 may fall a...
About Narcolepsy Clinical Trials in Orlando
Narcolepsy is a chronic neurological disorder that affects the brain's ability to control sleep-wake cycles, causing excessive daytime sleepiness and sudden loss of muscle tone (cataplexy). It is caused by a deficiency of the brain chemical hypocretin. Treatment includes stimulant medications and sodium oxybate.
There are currently 2 narcolepsy clinical trials recruiting participants in Orlando, FL. These studies are seeking a combined 136 participants. Research is being sponsored by Centessa Pharmaceuticals (UK) Limited, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Narcolepsy Clinical Trials in Orlando — FAQ
Are there narcolepsy clinical trials in Orlando?
Yes, there are 2 narcolepsy clinical trials currently recruiting in Orlando, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Orlando?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orlando research site will contact you about next steps.
Are clinical trials in Orlando free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orlando studies also compensate for your time and travel.
What narcolepsy treatments are being tested?
The 2 active trials in Orlando are testing new therapies including novel drugs, biologics, and treatment approaches for narcolepsy.
Data updated March 2, 2026 from ClinicalTrials.gov